{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:09:39Z","timestamp":1793196579915,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.coph.2017.10.004","type":"journal-article","created":{"date-parts":[[2017,11,5]],"date-time":"2017-11-05T18:11:22Z","timestamp":1509905482000},"page":"93-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["A new paradigm for GERD pathogenesis. Not acid injury, but cytokine-mediated inflammation driven by HIF-2\u03b1: a potential role for targeting HIF-2\u03b1 to prevent and treat reflux esophagitis"],"prefix":"10.1016","volume":"37","author":[{"given":"Rhonda F","family":"Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liela","family":"Bayeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart J","family":"Spechler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uttam K","family":"Tambar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K","family":"Bruick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2017.10.004_bib0150","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1001\/jama.1935.02760110034008","article-title":"Peptic esophagitis: a new clinical entity","volume":"104","author":"Winkelstein","year":"1935","journal-title":"JAMA"},{"key":"10.1016\/j.coph.2017.10.004_bib0155","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0016-5085(70)80004-X","article-title":"Histological consequences of gastroesophageal reflux in man","volume":"58","author":"Ismail-Beigi","year":"1970","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2017.10.004_bib0160","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0889-8553(21)00661-0","article-title":"Histology in the diagnosis of reflux esophagitis","volume":"19","author":"Frierson","year":"1990","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.coph.2017.10.004_bib0165","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1053\/j.gastro.2009.07.055","article-title":"Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury","volume":"137","author":"Souza","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2017.10.004_sbref0170","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.2016.5657","article-title":"Association of acute gastroesophageal reflux disease with esophageal histologic changes","volume":"315","author":"Dunbar","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.coph.2017.10.004_bib0175","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1113\/jphysiol.2008.157669","article-title":"Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation","volume":"586","author":"Taylor","year":"2008","journal-title":"J Physiol"},{"key":"10.1016\/j.coph.2017.10.004_bib0180","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMra0910283","article-title":"Hypoxia and inflammation","volume":"364","author":"Eltzschig","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2017.10.004_bib0185","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00109-007-0282-2","article-title":"Hypoxia inducible factor (HIF) function in innate immunity and infection","volume":"85","author":"Zinkernagel","year":"2007","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.coph.2017.10.004_bib0190","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10059-010-0067-2","article-title":"HIF-1 and HIF-2 transcription factors\u2014similar but not identical","volume":"29","author":"Loboda","year":"2010","journal-title":"Mol Cells"},{"key":"10.1016\/j.coph.2017.10.004_bib0195","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1053\/j.gastro.2008.03.009","article-title":"Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade","volume":"134","author":"Shah","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2017.10.004_bib0200","doi-asserted-by":"crossref","first-page":"G411","DOI":"10.1152\/ajpgi.00373.2007","article-title":"Mechanisms of oxidant production in esophageal squamous cell and Barrett's cell lines","volume":"294","author":"Feagins","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.coph.2017.10.004_sbref0205","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1136\/gutjnl-2016-312595","article-title":"Hypoxia-inducible factor-2\u03b1 plays a role in mediating oesophagitis in GORD","volume":"66","author":"Huo","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.coph.2017.10.004_bib0210","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1021\/acs.jmedchem.5b00529","article-title":"Isoform-selective and stereoselective inhibition of hypoxia inducible factor-2","volume":"58","author":"Scheuermann","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.coph.2017.10.004_bib0215","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.2174\/138161206777698783","article-title":"Natural product-derived small molecule activators of hypoxia-inducible factor-1 (HIF-1)","volume":"12","author":"Nagle","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.coph.2017.10.004_bib0220","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.drudis.2007.08.006","article-title":"Evaluation of HIF-1 inhibitors as anticancer agents","volume":"12","author":"Semenza","year":"2007","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.coph.2017.10.004_bib0225","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1111\/j.1582-4934.2009.00876.x","article-title":"Development of HIF-1 inhibitors for cancer therapy","volume":"13","author":"Onnis","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.coph.2017.10.004_bib0230","doi-asserted-by":"crossref","first-page":"17910","DOI":"10.1073\/pnas.0909353106","article-title":"Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization","volume":"106","author":"Lee","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2017.10.004_bib0235","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1073\/pnas.0808092106","article-title":"Artificial ligand binding within the HIF2\u03b1 PAS-B domain of the HIF2 transcription factor","volume":"106","author":"Scheuermann","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2017.10.004_bib0240","doi-asserted-by":"crossref","first-page":"17647","DOI":"10.1021\/ja9073062","article-title":"Principles of ligand binding within a completely buried cavity in HIF2\u03b1 PAS-B","volume":"131","author":"Key","year":"2009","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.coph.2017.10.004_bib0245","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nchembio.1185","article-title":"Allosteric inhibition of hypoxia inducible factor-2 with small molecules","volume":"9","author":"Scheuermann","year":"2013","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.coph.2017.10.004_bib0250","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm301847z","article-title":"Development of inhibitors of the PAS-B domain of the HIF-2\u03b1 transcription factor","volume":"56","author":"Rogers","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.coph.2017.10.004_bib0255","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nature14883","article-title":"Structural integration in hypoxia-inducible factors","volume":"524","author":"Wu","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.coph.2017.10.004_sbref0260","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1158\/0008-5472.CAN-16-0473","article-title":"A small-molecule antagonist of HIF2\u03b1 is efficacious in preclinical models of renal cell carcinoma","volume":"76","author":"Wallace","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.coph.2017.10.004_bib0265","volume":"4","author":"Butler","year":"1996"},{"key":"10.1016\/j.coph.2017.10.004_bib0270","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1016\/S0968-0896(02)00239-0","article-title":"5-Substituted-1H-tetrazoles as carboxylic acid isosteres: medicinal chemistry and synthetic methods","volume":"10","author":"Herr","year":"2002","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.coph.2017.10.004_bib0275","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature19796","article-title":"Targeting renal cell carcinoma with a HIF-2 antagonist","volume":"539","author":"Chen","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.coph.2017.10.004_bib0280","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature19795","article-title":"On-target efficacy of a HIF-2\u03b1 antagonist in preclinical kidney cancer models","volume":"539","author":"Cho","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.coph.2017.10.004_bib0285","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ncponc0403","article-title":"Lessons from phase III clinical trials on anti-VEGF therapy for cancer","volume":"3","author":"Jain","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.coph.2017.10.004_bib0290","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/cncr.28972","article-title":"Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway","volume":"121","author":"Hamnvik","year":"2015","journal-title":"Cancer"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489217301029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489217301029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T09:26:44Z","timestamp":1659778004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489217301029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":29,"alternative-id":["S1471489217301029"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2017.10.004","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new paradigm for GERD pathogenesis. Not acid injury, but cytokine-mediated inflammation driven by HIF-2\u03b1: a potential role for targeting HIF-2\u03b1 to prevent and treat reflux esophagitis","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2017.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}